Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Current Leases (2019 - 2025)

Historic Current Leases for Puma Biotechnology (PBYI) over the last 7 years, with Q3 2025 value amounting to $2.5 million.

  • Puma Biotechnology's Current Leases fell 5380.59% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 5380.59%. This contributed to the annual value of $5.5 million for FY2024, which is 1541.67% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Current Leases is $2.5 million, which was down 5380.59% from $4.4 million recorded in Q2 2025.
  • Puma Biotechnology's Current Leases' 5-year high stood at $5.7 million during Q1 2025, with a 5-year trough of $2.5 million in Q3 2025.
  • Moreover, its 5-year median value for Current Leases was $4.3 million (2023), whereas its average is $4.3 million.
  • As far as peak fluctuations go, Puma Biotechnology's Current Leases skyrocketed by 1773.31% in 2021, and later tumbled by 5380.59% in 2025.
  • Over the past 5 years, Puma Biotechnology's Current Leases (Quarter) stood at $3.6 million in 2021, then rose by 15.84% to $4.1 million in 2022, then increased by 15.94% to $4.8 million in 2023, then grew by 15.42% to $5.5 million in 2024, then tumbled by 55.42% to $2.5 million in 2025.
  • Its Current Leases was $2.5 million in Q3 2025, compared to $4.4 million in Q2 2025 and $5.7 million in Q1 2025.